Pain
News from the FDA/CDC
One in seven high schoolers is misusing opioids
Increased misuse among sexual minority youths warrants “tailored prevention strategies.”
Guidelines
AHA on cannabis: No evidence of heart benefits, but potential harms
The American Heart Association emphasizes potential risks and lack of benefits of cannabis for cardiovascular health.
Commentary
Exploring cannabis use by older adults
An exploration of trends in cannabis use by older adults and potential impact in terms of health is timely and important, said Kultaj Kaleka.
Feature
Move over supplements, here come medical foods
When it comes to medical foods, the FDA has often looked the other way because the ingredients may already have been proven safe and the danger to...
From the Journals
New insight into neurobehavioral effects of legalized cannabis
Cannabis consumption did not affect most short-term neurobehavioral measures, but it delayed recall memory and impaired balance.
News from the FDA/CDC
Use of nonopioid pain meds is on the rise
Prescription opioid use declined from 2009 to 2018, but not significantly.
Conference Coverage
New data back use of medical cannabis for epilepsy, pain, anxiety
Marijuana products linked to improved symptoms on a variety of fronts, research suggests, and adverse effects seem rare.
Conference Coverage
Managing pain expectations is key to enhanced recovery
Multimodal approach to postsurgery pain management can reduce or eliminate opioids for certain patient groups.
Conference Coverage
Is cannabis gaining acceptance as a treatment for neuropathic pain?
Some evidence supports cannabis as a treatment for neuropathic pain, but not everyone is convinced.
Latest News
Yoga is a good adjunct to migraine therapy
“All you need is a mat,” said Dr. Rohit Bhatia.
Commentary
Advice on treating rheumatic diseases from a COVID-19 epicenter
Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during...